Dr. Reddy's Laboratories Limited

NSEI:DRREDDY 株式レポート

時価総額:₹1.1t

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Dr. Reddy's Laboratories 配当金

配当金 基準チェック /56

Dr. Reddy's Laboratoriesは配当を支払う会社で、現在の利回りは0.66%ですが、利益によって十分にカバーされています。次の支払い日は 28th August, 2024で、権利落ち日は16th July, 2024 。

主要情報

0.6%

配当利回り

12%

配当性向

業界平均利回り0.8%
次回配当支払日28 Aug 24
配当落ち日16 Jul 24
一株当たり配当金n/a
一株当たり利益₹334.36
3年後の配当利回り予想0.6%

最近の配当金アップデート

Recent updates

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Jun 23
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Jun 20
Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

May 26
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

May 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

May 06
With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Apr 18
There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 02
Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Jan 19
Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Jan 01
Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

Oct 21
Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Oct 03
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Jul 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Jun 24
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Jun 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

May 27
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

May 13
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Apr 11
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

Jan 10
These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dec 05
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?

Sep 28
Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?

Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?

Aug 17
Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate

Jul 21
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00

Jul 08
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00

配当金の支払いについて

今日Jul 01 2024配当落ち日Jul 16 2024配当支払日Aug 28 202443 days 配当落ちから次の14 days 、次の配当を受け取るために購入する。

決済の安定と成長

配当データの取得

安定した配当: DRREDDYの1株当たり配当金は過去10年間安定しています。

増加する配当: DRREDDYの配当金は過去10年間にわたって増加しています。


配当利回り対市場

Dr. Reddy's Laboratories 配当利回り対市場
DRREDDY 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (DRREDDY)0.6%
市場下位25% (IN)0.3%
市場トップ25% (IN)1.1%
業界平均 (Pharmaceuticals)0.8%
3年後のアナリスト予想 (DRREDDY)0.6%

注目すべき配当: DRREDDYの配当金 ( 0.66% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) よりも高くなっています。

高配当: DRREDDYの配当金 ( 0.66% ) はIndian市場の配当金支払者の上位 25% ( 1.16% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: DRREDDYの配当性向は低く ( 12% )、配当金は利益によって十分にカバーされています。


株主配当金

キャッシュフローカバレッジ: DRREDDYの 現金配当性向 ( 37% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。


高配当企業の発掘